CAS 475086-01-2
:2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide
Description:
2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide, with CAS number 475086-01-2, is a synthetic organic compound characterized by its complex molecular structure, which includes a pyrazine ring and a sulfonamide functional group. This compound typically exhibits properties such as moderate solubility in organic solvents and potential bioactivity, making it of interest in pharmaceutical research. The presence of the diphenyl and pyrazinyl moieties suggests possible interactions with biological targets, potentially influencing its pharmacological profile. Additionally, the butoxy and methylsulfonyl groups may enhance its stability and solubility in biological systems. As a result, this compound may be investigated for its therapeutic applications, particularly in areas related to oncology or neuropharmacology, although specific biological activities would require empirical studies to elucidate its mechanism of action and efficacy. Overall, the structural features of this compound indicate a promising candidate for further research in medicinal chemistry.
Formula:C26H32N4O4S
InChI:InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)
InChI key:InChIKey=QXWZQTURMXZVHJ-UHFFFAOYSA-N
SMILES:N(CCCCOCC(NS(C)(=O)=O)=O)(C(C)C)C=1N=C(C(=NC1)C2=CC=CC=C2)C3=CC=CC=C3
Synonyms:- 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide
- 2-[4-[(5,6-Diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
- Acetamide, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
- Acetamide, 2-[4-[(5,6-diphenylpyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)-
- Act 293987
- Ns 304
- Selexipag
- Uptravi
- Slipper
- Selexipag (10mM in DMSO)
- Selexipag(NS-304)
- Selexipag intermediate 1
- 2-[4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamine]butyloxy]-N-(methylsulfonyl)acetamide
- Selexipag intermediate 2
- SELEXIPAG;ACT293987;NS304;NS 304;ACT 293987;ACT-293987
- NS-304;ACT-293987
- Selexipag API
- (2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)acetate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 11 products.
Ref: IN-DA00DAAW
1g168.00€5g548.00€10gTo inquire1mg44.00€25gTo inquire2mg50.00€5mg52.00€10mg70.00€50mg123.00€100mg118.00€250mg141.00€2-(4-((5,6-Diphenylpyrazin-2-Yl)(Isopropyl)Amino)Butoxy)-N-(Methylsulfonyl)Acetamide
CAS:2-(4-((5,6-Diphenylpyrazin-2-Yl)(Isopropyl)Amino)Butoxy)-N-(Methylsulfonyl)AcetamidePurity:98%Molecular weight:496.62g/molSelexipag
CAS:Formula:C26H32N4O4SPurity:>98.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:496.63Selexipag
CAS:<p>Selexipag (ACT-293987, NS-304) is a drug for PAH that dilates pulmonary vessels.</p>Formula:C26H32N4O4SPurity:99.98% - >99.99%Color and Shape:SolidMolecular weight:496.62Selexipag
CAS:Controlled Product<p>Applications Selexipag is an orally available, highly selective, long-acting prostacyclin (IP) receptor agonist prodrug. It is a potential drug for the treatment of various vascular disorders such as pulmonary arterial hypertension and arteriosclerosis obliterans.<br>References Kuwano, K., et al.: J. Pharm. Exp. Ther., 322, 1181 (2007);<br></p>Formula:C26H32N4O4SColor and Shape:Light YellowMolecular weight:496.62Selexipag
CAS:<p>Non-prostanoid IP receptor agonist</p>Formula:C26H32N4O4SPurity:Min. 95%Color and Shape:PowderMolecular weight:496.60 g/molSelexipag-d10
CAS:Controlled ProductFormula:C26D10H22N4O4SColor and Shape:NeatMolecular weight:506.683







